Derma Sciences Inc. (DSCI.OB) to Launch Compression Therapy Device to Give Chronic Venous Insufficiency Patients Mobility
Derma Sciences Inc. (OTCBB: DSCI) manufactures and markets advanced wound-care products around the world. The company today announced it will commence the sale of its novel MOBILITY1 Intermittent Pneumatic Compression Therapy Device beginning in October. The commercial launch will allow the company to target the nearly 7 million people afflicted with chronic venous insufficiency. Derma Sciences will launch MOBILITY 1 after introducing the product to vascular surgeons at the 9th Annual New Cardiovascular Horizons (NCVH) Conference, September 10-13, 2008, in New Orleans. MOBILITY 1 is used for the treatment of chronic venous insufficiency, venous leg ulcers, lymphadema, the prevention of…